AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16752286 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium phosphate cement augmentation
Number of subjects: 118
Study 16752286 — intervention group
Group type: COMPARATOR
Intervention: Control group (closed reduction and fixation with two cannulated screws)
Number of subjects: 118
Study 14997032 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose p38 MAPK inhibitor (BIRB 796 BS) 600 mg
Number of subjects: 24
Study 14997032 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose p38 MAPK inhibitor (BIRB 796 BS) 50 mg
Number of subjects: 24
Study 14997032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 11766105 — intervention group
Group type: EXPERIMENTAL
Intervention: Mercurochrome
Number of subjects: 72
Study 11766105 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole
Number of subjects: 72
Study 11766105 — intervention group
Group type: COMPARATOR
Intervention: Locacorten-vioform
Number of subjects: 72
Study 9412209 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1 g once daily parenterally
Number of subjects: 148
Study 9412209 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime 1 g 8 hourly for a minimum of 7 days
Number of subjects: 148
Study 8314099 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (individual and family counseling, support group participation, and ad hoc consultation)
Number of subjects: 2
Study 8314099 — intervention group
Group type: COMPARATOR
Intervention: Control group (only routine support)
Number of subjects: 2
Study 2945652 — intervention group
Group type: EXPERIMENTAL
Intervention: Colon Perfusion Fluid ¢ñ
Number of subjects: 19
Study 2945652 — intervention group
Group type: COMPARATOR
Intervention: Hemodialysis
Number of subjects: 19
Study 30130147 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Dex measurement using the L-Dex U400 device
Number of subjects: 280
Study 30130147 — intervention group
Group type: COMPARATOR
Intervention: Normative values for L-Dex
Number of subjects: 280
Study 26720598 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week supervised pelvic floor muscle exercise (PFME) program
Number of subjects: 70
Study 26720598 — intervention group
Group type: COMPARATOR
Intervention: Control group (PFME and stop test training)
Number of subjects: 70
Study 25261967 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity (BMI ≥30 kg/m²)
Number of subjects: 6729
Study 21863338 — intervention group
Group type: EXPERIMENTAL
Intervention: VivaGel(®)
Number of subjects: 61
Study 21863338 — intervention group
Group type: COMPARATOR
Intervention: Placebo gels
Number of subjects: 61
Study 21863338 — intervention group
Group type: COMPARATOR
Intervention: All gels (including VivaGel(®) and placebo)
Number of subjects: 61
Study 20199360 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour 10-mg controlled-release vaginal dinoprostone pessary
Number of subjects: 133
Study 20199360 — intervention group
Group type: COMPARATOR
Intervention: Repeat doses of 2 mg vaginal dinoprostone gel
Number of subjects: 133
Study 18544523 — intervention group
Group type: EXPERIMENTAL
Intervention: Ametop
Number of subjects: 20
Study 18544523 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA
Number of subjects: 20
Study 18544523 — intervention group
Group type: COMPARATOR
Intervention: Control cream
Number of subjects: 20
Study 15660542 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline group - catheters flushed with 3 mL of normal saline 0.9% after each catheter use
Number of subjects: 300
Study 15660542 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin group - catheters flushed with 3 mL of 100-U/mL heparin in normal saline 0.9% after each catheter use
Number of subjects: 300
Study 15660542 — intervention group
Group type: COMPARATOR
Intervention: Control group - catheters not flushed following drug administration
Number of subjects: 300
Study 12647328 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 136
Study 12647328 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-Limited Dynamic Psychotherapy (TLDP)
Number of subjects: 136
Study 10483544 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel containing 0.5 mg of dinoprostone placed intracervically every four hours
Number of subjects: 69
Study 10483544 — intervention group
Group type: COMPARATOR
Intervention: Polymer insert containing 10 mg of dinoprostone intravaginally
Number of subjects: 69
Study 8673544 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV‐1 immunogen (inactivated, gp120‐depleted HIV‐1 virus in incomplete Freund's adjuvant)
Number of subjects: 0
Study 8673544 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant control
Number of subjects: 0
Study 8673544 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV‐1 immunogen
Number of subjects: 0
Study 1833167 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3 prophylaxis
Number of subjects: 0
Study 1833167 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine prophylaxis
Number of subjects: 0
Study 6349926 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily vitamin supplementation
Number of subjects: 0
Study 6349926 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31928445 — intervention group
Group type: EXPERIMENTAL
Intervention: Thirty days exposure to time-estimation tasks
Number of subjects: 22
Study 31928445 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (without exposure to time estimation tasks)
Number of subjects: 22
Study 30710565 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation of the auricular branch of the vagus nerve (tVNS)
Number of subjects: 97
Study 30710565 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (earlobe)
Number of subjects: 97
Study 29040124 — intervention group
Group type: EXPERIMENTAL
Intervention: XLPE liner (Marathon; DePuy)
Number of subjects: 122
Study 29040124 — intervention group
Group type: COMPARATOR
Intervention: Conventional UHMWPE liner (Enduron; DePuy)
Number of subjects: 122
Study 29040124 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 122
Study 27339715 — intervention group
Group type: EXPERIMENTAL
Intervention: E-Coach intervention with condition-specific customization, in-hospital and post-discharge support by a care transition nurse, interactive voice response post-discharge calls, and CTN follow-up
Number of subjects: 511
Study 27339715 — intervention group
Group type: EXPERIMENTAL
Intervention: E-Coach intervention
Number of subjects: 511
Study 27339715 — intervention group
Group type: COMPARATOR
Intervention: Usual post-discharge care (UC)
Number of subjects: 511
Study 24500308 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol-centred therapy (IV and oral)
Number of subjects: 0
Study 24500308 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol-centred therapy
Number of subjects: 0
Study 24500308 — intervention group
Group type: COMPARATOR
Intervention: Cinacalcet-centred therapy
Number of subjects: 0
Study 21790773 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HbA(1c) values
Number of subjects: 845
Study 21790773 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA(1c) cut-off of 43 mmol/mol (6.05%)
Number of subjects: 845
Study 21790773 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA(1c) ≥ 48 mmol/mol (≥ 6.5%)
Number of subjects: 845
Study 19669013 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg.kg‐1 of 0.375% bupivacaine associated with 150 (1/4)g of clonidine (2 mL)
Number of subjects: 30
Study 19669013 — intervention group
Group type: COMPARATOR
Intervention: 1.5 mg.kg‐1 of 0.375% bupivacaine associated with NS (2 mL)
Number of subjects: 30
Study 16627543 — intervention group
Group type: EXPERIMENTAL
Intervention: 90Y and triamcinolone
Number of subjects: 66
Study 16627543 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular glucocorticoids alone (placebo and triamcinolone)
Number of subjects: 66
Study 15592273 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactive endometrium
Number of subjects: 93
Study 15592273 — intervention group
Group type: EXPERIMENTAL
Intervention: Proliferative endometrium
Number of subjects: 93
Study 15592273 — intervention group
Group type: EXPERIMENTAL
Intervention: Secretory endometrium
Number of subjects: 93
Study 15592273 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial polyps
Number of subjects: 93
Study 11288210 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized epinephrine (0.5 mg of 0.1% solution)
Number of subjects: 30
Study 11288210 — intervention group
Group type: COMPARATOR
Intervention: Nebulized salbutamol (2.5 mg)
Number of subjects: 30
Study 11288210 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized epinephrine
Number of subjects: 30
Study 11288210 — intervention group
Group type: COMPARATOR
Intervention: Nebulized salbutamol
Number of subjects: 30
Study 9146453 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral counseling plus incentives
Number of subjects: 28
Study 9146453 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral counseling
Number of subjects: 28
Study 9146453 — intervention group
Group type: COMPARATOR
Intervention: Health risk assessment
Number of subjects: 28
Study 9146453 — intervention group
Group type: COMPARATOR
Intervention: Risk factor education
Number of subjects: 28
Study 8196140 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-1ra (100 mg loading dose followed by 1.0 or 2.0 mg/kg per hour continuous infusion)
Number of subjects: 893
Study 8196140 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-1ra
Number of subjects: 893
Study 3215873 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training (HI)
Number of subjects: 17
Study 3215873 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity training (LI)
Number of subjects: 17
Study 30795802 — intervention group
Group type: EXPERIMENTAL
Intervention: intravitreal ranibizumab therapy
Number of subjects: 0
Study 27861329 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite implant
Number of subjects: 281
Study 27861329 — intervention group
Group type: COMPARATOR
Intervention: Acrylic implant
Number of subjects: 281
Study 24946024 — intervention group
Group type: EXPERIMENTAL
Intervention: PS10 (IPAP 14 & EPAP 4 cm H2O)
Number of subjects: 10
Study 24946024 — intervention group
Group type: EXPERIMENTAL
Intervention: PS0 (IPAP & EPAP 4 cm H2O)
Number of subjects: 10
Study 24946024 — intervention group
Group type: COMPARATOR
Intervention: noPS (no ventilator)
Number of subjects: 10
Study 23183315 — intervention group
Group type: EXPERIMENTAL
Intervention: Deception
Number of subjects: 0
Study 23183315 — intervention group
Group type: EXPERIMENTAL
Intervention: Misinformation
Number of subjects: 0
Study 21996600 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric bypass (GB)
Number of subjects: 32
Study 21996600 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy (SG)
Number of subjects: 32
Study 18470666 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (25 subjects)
Number of subjects: 50
Study 15346340 — intervention group
Group type: EXPERIMENTAL
Intervention: Dryvax vaccination in previously vaccinated individuals
Number of subjects: 30
Study 15346340 — intervention group
Group type: EXPERIMENTAL
Intervention: Dryvax vaccination in vaccinia-naive individuals
Number of subjects: 30
Study 12026534 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal replacement therapy (hemodialysis and kidney transplantation)
Number of subjects: 89
Study 12026534 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney transplantation
Number of subjects: 89
Study 12026534 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) session
Number of subjects: 89
Study 12026534 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful kidney transplantation and single HD session
Number of subjects: 89
Study 12026534 — intervention group
Group type: COMPARATOR
Intervention: Erythropoietin treatment
Number of subjects: 89
Study 9675631 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial interventions (performance contingent verbal feedback and planned interpersonal interaction in small groups)
Number of subjects: 0
Study 9675631 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 8008408 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% sucrose
Number of subjects: 42
Study 8008408 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 42
Study 2683758 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-Tac monoclonal antibody (20 mg, administered intravenously daily for 10 days)
Number of subjects: 0
Study 2683758 — intervention group
Group type: COMPARATOR
Intervention: Control (cyclosporine plus prednisone or cyclosporine plus azathioprine plus prednisone)
Number of subjects: 0
Study 2683758 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-Tac monoclonal antibody
Number of subjects: 0
Study 1089438 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of phenol into the lumbar sympathetic chain
Number of subjects: 25
Study 1089438 — intervention group
Group type: COMPARATOR
Intervention: Injection of local anaesthetic subcutaneously (Control)
Number of subjects: 25
Study 1089438 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill testing
Number of subjects: 25
Study 1089438 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf blood pressure response following exercise
Number of subjects: 25
Study 31177752 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO) 3 g/day for 6 months
Number of subjects: 180
Study 31177752 — intervention group
Group type: EXPERIMENTAL
Intervention: Perilla oil (PO) 3 g/day for 6 months
Number of subjects: 180
Study 31177752 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil mixed with linseed oil (FLO) 3 g/day for 6 months
Number of subjects: 180
Study 28486976 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboprophylaxis with low-molecular-weight heparin (LMWH) at a dose of 85 IU/kg once daily during asparaginase courses of ALL treatment
Number of subjects: 324
Study 28486976 — intervention group
Group type: COMPARATOR
Intervention: No thromboprophylaxis (standard of care) during asparaginase courses of ALL treatment
Number of subjects: 324
Study 28486976 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboprophylaxis with LMWH
Number of subjects: 324
Study 25439084 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + usual treatment
Number of subjects: 50
Study 25439084 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment
Number of subjects: 50
Study 22544420 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory training
Number of subjects: 3479
Study 22544420 — intervention group
Group type: COMPARATOR
Intervention: Didactic training (control_1)
Number of subjects: 3479
Study 22544420 — intervention group
Group type: COMPARATOR
Intervention: Didactic training (control_2)
Number of subjects: 3479
Study 22097092 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (0.5 mg kg(‐1))
Number of subjects: 60
Study 22097092 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fentanyl (1 microg kg(‐1))
Number of subjects: 60
Study 19857084 — intervention group
Group type: EXPERIMENTAL
Intervention: GoChi (Lycium barbarum fruit juice) at 120 mL/day for 30 days
Number of subjects: 60
Study 19857084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 16707546 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 8290
Study 16707546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8290
Study 15546593 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS over left DLPFC (12 sessions, alternate days)
Number of subjects: 11
Study 15546593 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (placebo)
Number of subjects: 11
Study 11505341 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP) with 2 periods of 2‐minute ischemia followed by 3‐minute reperfusion
Number of subjects: 80
Study 11505341 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP)
Number of subjects: 80
Study 11505341 — intervention group
Group type: COMPARATOR
Intervention: Stable control
Number of subjects: 80
Study 11505341 — intervention group
Group type: COMPARATOR
Intervention: Unstable control
Number of subjects: 80
Study 11505341 — intervention group
Group type: EXPERIMENTAL
Intervention: Unstable IP
Number of subjects: 80
Study 11505341 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable IP
Number of subjects: 80
Study 9519518 — intervention group
Group type: EXPERIMENTAL
Intervention: Information leaflet
Number of subjects: 1014
Study 9519518 — intervention group
Group type: COMPARATOR
Intervention: No leaflet (control)
Number of subjects: 1014
Study 9519518 — intervention group
Group type: EXPERIMENTAL
Intervention: Information leaflet (in patients treated with antibiotics)
Number of subjects: 1014
Study 9519518 — intervention group
Group type: COMPARATOR
Intervention: No leaflet (control, in patients treated with antibiotics)
Number of subjects: 1014
Study 8287585 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (5 mg)
Number of subjects: 30
Study 8287585 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (2.4 mg)
Number of subjects: 30
Study 8287585 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (1 ml)
Number of subjects: 30
Study 3816314 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol aerosol via inhalation aids (InspirEase, Aerochamber, Aerosol Bag)
Number of subjects: 20
Study 3816314 — intervention group
Group type: COMPARATOR
Intervention: Albuterol aerosol via MDI mouthpiece
Number of subjects: 20
Study 3816314 — intervention group
Group type: COMPARATOR
Intervention: Placebo via inhalation aids
Number of subjects: 20
Study 3816314 — intervention group
Group type: COMPARATOR
Intervention: Placebo via MDI mouthpiece
Number of subjects: 20
Study 30114338 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual linear scale (0% to 100%)
Number of subjects: 0
Study 30114338 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnifier scale (after clicking)
Number of subjects: 0
Study 30114338 — intervention group
Group type: COMPARATOR
Intervention: Open-ended response mode
Number of subjects: 0
Study 26767384 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor (0.5 mg as eye drops for 10 days)
Number of subjects: 18
Study 26767384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 23886739 — intervention group
Group type: EXPERIMENTAL
Intervention: 66 mg/mL iodine
Number of subjects: 0
Study 23886739 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/mL iodine
Number of subjects: 0
Study 23886739 — intervention group
Group type: COMPARATOR
Intervention: >133 mg/mL iodine
Number of subjects: 0
Study 21903969 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative sleeping device
Number of subjects: 41
Study 21903969 — intervention group
Group type: COMPARATOR
Intervention: Normal sleeping device (control)
Number of subjects: 41
Study 20433339 — intervention group
Group type: EXPERIMENTAL
Intervention: LSVT(R)
Number of subjects: 26
Study 20433339 — intervention group
Group type: COMPARATOR
Intervention: Traditional dysarthria therapy (TRAD)
Number of subjects: 26
Study 18458698 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 1 mg/kg followed by 250 µg/(kg·min)
Number of subjects: 30
Study 18458698 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 30
Study 18458698 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 30
Study 16148243 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer
Number of subjects: 94
Study 16148243 — intervention group
Group type: COMPARATOR
Intervention: Control group (brief physician endorsement, handout, follow-up calls)
Number of subjects: 94
Study 12011126 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta 150 IU/kg
Number of subjects: 349
Study 12011126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 349
Study 10443336 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy milk supplement (1 litre daily for 4 weeks)
Number of subjects: 10
Study 10443336 — intervention group
Group type: COMPARATOR
Intervention: Rice dream (vegetable protein control)
Number of subjects: 10
Study 10443336 — intervention group
Group type: COMPARATOR
Intervention: Semi-skimmed cow's milk (animal protein control)
Number of subjects: 10
Study 8527268 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg orally with grapefruit juice
Number of subjects: 16
Study 8527268 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine 2.5 mg intravenously with grapefruit juice
Number of subjects: 16
Study 8527268 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg orally
Number of subjects: 16
Study 8527268 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine 2.5 mg intravenously
Number of subjects: 16
Study 2240630 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthetic regimen with nitrous oxide (N2O)
Number of subjects: 270
Study 2240630 — intervention group
Group type: COMPARATOR
Intervention: Anesthetic regimen without nitrous oxide (Control)
Number of subjects: 270
Study 340305 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (Anafranil) plus behaviour therapy
Number of subjects: 0
Study 340305 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine plus simulated behaviour therapy
Number of subjects: 0
Study 340305 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine alone
Number of subjects: 0
Study 340305 — intervention group
Group type: COMPARATOR
Intervention: Behaviour therapy alone
Number of subjects: 0
Study 30570305 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and prolonged chewing intervention (4 sessions)
Number of subjects: 46
Study 30570305 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 46
Study 27502452 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform-switching concept (abutment 3.8 mm in diameter)
Number of subjects: 22
Study 27502452 — intervention group
Group type: COMPARATOR
Intervention: Standard restoration (abutment 5.5 mm in diameter)
Number of subjects: 22
Study 25245625 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole 40 mg daily for 4 weeks
Number of subjects: 408
Study 25245625 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg daily for 8 weeks
Number of subjects: 408